Core Laboratories Reports Q3 2026 Results, Issues Q4 Guidance
Core Laboratories reported Q3 2026 revenue of $132.1 million, GAAP operating income of $12.1 million and GAAP EPS of $0.12. It projected Q4 revenue of $128.5 million to $134.5 million and EPS of $0.12 to $0.20.
Core Laboratories reported third quarter 2026 revenue of $132.1 million and GAAP operating income of $12.1 million, resulting in GAAP EPS of $0.12. Excluding certain items, operating income was $12.6 million with EPS of $0.16. The company provided fourth quarter 2026 guidance, projecting revenue between $128.5 million and $134.5 million and EPS in the range of $0.12 to $0.20. Additionally, the Board of Directors approved a quarterly cash dividend of $0.01 per share, payable on November 30, 2026, to shareholders of record on November 9, 2026.
Management noted that international demand drove sequential growth, though regional disruptions in the Middle East and Russia-Ukraine continued to impact operations.